[ET Net News Agency, 15 April 2024] REMEGEN (09995) fell 10.1% to HK$29, dipping below
the 100-D SMA of HK$29.496.
It hits an intra-day low of HK$29, and an intra-day high of HK$31.95. The total shares
traded was 1.74 million, with a value of HK$52m. The active buy/sell ratio is 33:67, with
net selling turnover of HK$16.54m. CITIGROUP GLOBAL accounts for greatest net responsive
buying turnover of HK$4.06m, with volume weighted average price of HK$29.538. CHINA
INNOVATION MARKET SER accounts for greatest net responsive selling turnover of HK$2.58m,
with volume weighted average price of HK$29.829. The stock has fallen a combined 11.5%
over the past 2 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 29.000 % Chg -10.08%
High 31.950 Low 29.000
Shares Tr 1.74m Turnover 52m
10-D SMA 29.825 %H.V 74.844
20-D SMA 28.710 VWAP 29.860
50-D SMA 23.641 RSI14 54.226
----------------------------------
Status: Dipping below the 100-D SMA, active buy/sell ratio is 33:67, with net selling
turnover of HK$16.54m, falling a combined 11.5% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
REMEGEN (09995) 29.00 -10.08
HUTCHMED (00013) 28.05 -3.11
GENSCRIPT BIO (01548) 12.10 -5.17
INNOVENT BIO (01801) 35.65 -4.55
EVEREST MED-B (01952) 24.65 -5.74
LAEKNA-B (02105) 8.20 +70.48
WUXI BIO (02269) 13.64 -1.87
TIGERMED (03347) 32.40 +0.47
BEIGENE (06160) 83.15 -2.98
AKESO (09926) 48.20 -2.63
---------------------------------------------
(ed)